{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:45:59Z","timestamp":1773938759273,"version":"3.50.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Irreversible electroporation has been proved as a feasible and safe method against tumor in liver. However, few studies focused on tumors adjacent to perihepatic important structure like vessels, biliary system and gall bladder. These structures limit the effectiveness of conventional treatments. The aim of this article is to analyze the clinical outcomes of patients with hepatic tumors at the special sites who received IRE treatment and provide reliable evidence for broadening the scope of IRE\u2019s clinical application.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The clinical information of patients who underwent IRE ablation for tumors adjacent to perihepatic important structure between February 2017 and December 2021 was collected and retrospectively analyzed. All patients underwent contrast-enhanced CT or MRI for further evaluation at the 1-month follow-up and every 3 months thereafter. Post-ablation complications, recurrence, progression-free survival and overall survival were evaluated to analyze the prognosis of IRE ablation adjacent to perihepatic important structure. Categorical variables are presented as numbers followed by percentages. Continuous data are presented as the mean \u00b1 deviation. The tumor size and IRE ablation size were evaluated by the maximum diameters.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Thirty-two patients who underwent IRE ablation for tumor adjacent to perihepatic important structure were studied in this research. There were 39 lesions in 32 patients treated with IRE ablation. Fourteen of them (35.9%) were located adjacent to the porta hepatis, and 8 of them (20.5%) were located adjacent to the hepatocaval confluence. Subcapsular lesions accounted for 15.4% (6 of 39 lesions). The other 11 lesions were in the para gallbladder (5 of 39 lesions, 12.8%), the caudate lobe (5 of 39 lesions, 12.8%) and the colonic hepatic flexure (1 of 39 lesions, 2.6%). According to the Clavien\u2212Dindo classification system for complications, all relative patients with cancer experienced complications below class III except one patient who developed postoperative hemorrhagic shock and improved after timely treatment. Recurrence <jats:italic>in situ<\/jats:italic> was observed in 5 of 32 (15.6%) patients. The median PFS of the patients who received IRE ablation was 384 days, and the median OS was 571 days.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>IRE ablation is a feasible and safe treatment strategy for tumors adjacent to perihepatic important structure. With improved equipment, optimized therapeutic parameters and long-term clinical trials, IRE will play an increasingly important role in the treatment of tumors in liver.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2024.1387952","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T04:14:06Z","timestamp":1726114446000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["A retrospective study of irreversible electroporation for tumors adjacent to perihepatic important structure"],"prefix":"10.3389","volume":"14","author":[{"given":"Ju","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaojie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-006-9068-y","article-title":"Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy","volume":"14","author":"Kornprat","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200206000-00002","article-title":"Trends in long-term survival following liver resection for hepatic colorectal metastases","volume":"235","author":"Choti","year":"2002","journal-title":"Ann Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08776-0","article-title":"Recurrence after liver resection of colorectal liver metastases: repeat resection or ablation followed by hepatic arterial infusion pump chemotherapy","volume":"28","author":"Buisman","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.783236","article-title":"Strategies to improve the antitumor effect of immunotherapy for hepatocellular carcinoma","volume":"12","author":"Xing","year":"2021","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.JCRT_101_20","article-title":"Transarterial chemoembolization, ablation, tyrosine kinase inhibitors, and immunotherapy (TATI): A novel treatment for patients with advanced hepatocellular carcinoma","volume":"16","author":"Meng","year":"2020","journal-title":"J Cancer Res Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-011-1716-2","article-title":"Long-term outcome of percutaneous ablation in very early-stage hepatocellular carcinoma","volume":"15","author":"Kuang","year":"2011","journal-title":"J Gastrointest Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"235026","DOI":"10.1088\/1361-6560\/aaeef9","article-title":"An analytical solution for temperature distributions in hepatic radiofrequency ablation incorporating the heat-sink effect of large vessels","volume":"63","author":"Chen","year":"2018","journal-title":"Phys Med Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s40792-018-0534-0","article-title":"Perforation of the esophagus due to thermal injury after laparoscopic radiofrequency ablation for hepatocellular carcinoma: a case for caution","volume":"4","author":"Yamane","year":"2018","journal-title":"Surg Case Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2433060157","article-title":"Percutaneous radiofrequency ablation of hepatic tumors against the diaphragm: frequency of diaphragmatic injury","volume":"243","author":"Head","year":"2007","journal-title":"Radiology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-07846-5","article-title":"Irreversible electroporation (IRE) in renal cell carcinoma (RCC): a mid-term clinical experience","volume":"31","author":"Wah","year":"2021","journal-title":"Eur Radiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","article-title":"Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma","volume":"18","author":"Llovet","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021203089","article-title":"Irreversible electroporation to treat unresectable colorectal liver metastases (COLDFIRE-2): A phase II, two-center, single-arm clinical trial","volume":"299","author":"Meijerink","year":"2021","journal-title":"Radiology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-07742-y","article-title":"Efficacy and safety of irreversible electroporation for Malignant liver tumors: a systematic review and meta-analysis","volume":"31","author":"Gupta","year":"2021","journal-title":"Eur Radiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/0300060519898012","article-title":"Massive abdominal hemorrhage after radiofrequency ablation of recurrent hepatocellular carcinoma with successful hemostasis achieved through transarterial embolization: a case report","volume":"48","author":"Shi","year":"2020","journal-title":"J Int Med Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.diii.2020.09.005","article-title":"Percutaneous ablation of obscure hypovascular liver tumours in challenging locations using arterial CT-portography guidance","volume":"101","author":"Schembri","year":"2020","journal-title":"Diagn Interv Imaging"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2020.11.010","article-title":"Liver tumor ablation in difficult locations: Microwave ablation of perivascular and subdiaphragmatic hepatocellular carcinoma","volume":"71","author":"Makovich","year":"2021","journal-title":"Clin imaging"},{"key":"B19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2214\/AJR.14.12879","article-title":"Microwave ablation of hepatic tumors abutting the diaphragm is safe and effective","volume":"204","author":"Smolock","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2021.624817","article-title":"Case report: cytoreductive surgery and HIPEC associated with liver electrochemotherapy in a cholangiocarcinoma patient with peritoneal carcinomatosis and liver metastasis case report","volume":"8","author":"Stefano","year":"2021","journal-title":"Front Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/153303460700600106","article-title":"Irreversible electroporation: a new ablation modality\u2013clinical implications","volume":"6","author":"Rubinsky","year":"2007","journal-title":"Technol Cancer Res Treat"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10081609","article-title":"Irreversible electroporation (IRE) in locally advanced pancreatic cancer: A review of current clinical outcomes, mechanism of action and opportunities for synergistic therapy","volume":"10","author":"Rai","year":"2021","journal-title":"J Clin Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2017-0061","article-title":"State of the ablation nation: a review of ablative therapies for cure in the treatment of hepatocellular carcinoma","volume":"13","author":"Salati","year":"2017","journal-title":"Future Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/17434440.2018.1425612","article-title":"Technology of irreversible electroporation and review of its clinical data on liver cancers","volume":"15","author":"Cohen","year":"2018","journal-title":"Expert Rev Med Devices"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29060316","article-title":"Percutaneous ablation of hepatic tumors at the hepatocaval confluence using irreversible electroporation: A preliminary study","volume":"29","author":"Li","year":"2022","journal-title":"Curr Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5114\/wo.2016.57815","article-title":"Irreversible electroporation in the treatment of locally advanced pancreas and liver metastases of colorectal carcinoma","volume":"20","author":"Wichtowski","year":"2016","journal-title":"Contemp Oncol (Pozn)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-019-02164-2","article-title":"Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience","volume":"42","author":"Kalra","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.678490","article-title":"Comparison of percutaneous radiofrequency ablation for subcapsular and non-subcapsular colorectal cancer liver metastases","volume":"11","author":"Fan","year":"2021","journal-title":"Front Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"20220086","DOI":"10.1259\/bjr.20220086","article-title":"Percutaneous ablative therapies for hepatocellular carcinoma in the caudate lobe of the liver: efficacy and outcome","volume":"96","author":"Mukund","year":"2023","journal-title":"Br J Radiol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1387952\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T04:14:08Z","timestamp":1726114448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1387952\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":29,"alternative-id":["10.3389\/fonc.2024.1387952"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1387952","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"article-number":"1387952"}}